The maker of the EpiPen is hoping to end the controversy surrounding it by offering a generic version of the life-saving drug.
Pharmaceutical company Mylan announced Monday it will launch an alternative to the EpiPen at half the price.
While the cost of two generic injectors of the emergency allergy drug will still be pricey at $300, Mylan has been facing severe criticism for the $600 price tag for a pair of EpiPens.
Thank you for reading the Springfield News-Sun and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.
Thank you for supporting in-depth local journalism with your subscription to the Springfield News-Sun. Get more news when you want it with email newsletters just for subscribers. Sign up here.